SMECX Mutual Fund

SMECX Mutual Fund

NAV$8.36
See how much of SMECX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free
Showing the top 10 of 80 holdings · as of Sep 30, 2026
Top 10 weight
21.07%
SMECX top 10 holdings, by weight
#TickerNameWeightCumulativeSharesMkt valueSectorIndustry
1
CRL
Charles River Laboratories International IncHealth Care · Life Sciences Tools
2.50%
2.5%91,349$26.95MHealth CareLife Sciences Tools
2
SANM
Sanmina CorpInfo Tech · Electronic Equipment
2.46%
5.0%123,181$26.47MInfo TechElectronic Equipment
Share changes, sector and industry · Pro
3
HALO
Halozyme Therapeutics Inc
2.25%
7.2%219,247$24.20M
4
AIT
Applied Industrial Technologies Inc
2.23%
9.4%72,215$24.00M
5
GH
Guardant Health, Inc
2.10%
11.5%127,130$22.67M
6
IESC
Ies Holdings, Inc.
2.10%
13.6%70,528$22.65M
7
BTSG
Brightspring Health
1.97%
15.6%373,912$21.22M
8
WCC
Wesco International Inc
1.86%
17.5%55,780$20.06M
9
ICLR
Icon Plc Ordinary Shares
1.83%
19.3%116,299$19.77M
10
WTFC
Wintrust Financial Corp
1.77%
21.1%134,400$19.06M
More holdings · Pro
FundXLS Pro
See the other 70 holdings of SMECX
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime
Themes in the top 10
ManufacturingSupply ChainSemiconductorsNetworking InfrastructureConnectors & InterconnectsBiotechnologyPharmaceuticalsLife Sciences ToolsDigital HealthInfrastructureAging PopulationManaged CareGlobal BankingLending & CreditDigital Banking

SMECX Mutual Fund Top Holdings

SMECX holdings top 10 positions. The top 10 holdings account for 21.1% of the fund, led by Charles River Laboratories International Inc at 2.5%, Sanmina Corp at 2.5%, Halozyme Therapeutics Inc at 2.3%.

SMECX portfolio concentration is well-diversified, with the top 10 representing 21.1% of total assets. The largest sector exposure is Information Technology at 18.8%.

SMECX sectors provide a detailed breakdown. SMECX overlap shows how holdings compare to other funds in your portfolio.